Withdrawal: Clinical Analysis of Immune-Related Adverse Events in 78 Patients with Advanced Metastatic Lung Cancer Treated with Immune Checkpoint Inhibitors, published in The Journal of Clinical Pharmacology, [10.1002/jcph.2395]

J Clin Pharmacol. 2024 Aug;64(8):1048. doi: 10.1002/jcph.2395. Epub 2024 Apr 2.

Abstract

The above article, published online on 14th December 2023 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the journal Editor in Chief, John van Den Anker, and Wiley Periodicals LLC. The withdrawal has been agreed following no response from the author to requests to sign the Journal's publishing license/to requests to approve their article proof for publication.

Publication types

  • Retracted Publication

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Immune Checkpoint Inhibitors* / adverse effects
  • Immune Checkpoint Inhibitors* / therapeutic use
  • Lung Neoplasms* / drug therapy
  • Male
  • Middle Aged
  • Neoplasm Metastasis

Substances

  • Immune Checkpoint Inhibitors